Skip to main content
. 2021 Dec 23;39(2):153–163. doi: 10.1007/s40266-021-00913-y

Fig. 3.

Fig. 3

Percentage of older adults in each category of change in dose of concomitant medications at the follow-up visit after starting medical cannabis use. Note that percentage of users who indicated ‘unsure’ about change in medication dose are not displayed (opioids = 5.4%; nerve modulators = 4.5%; antidepressants = 6.7%; benzodiazepines = 15.8%)